Pelthos Therapeutics Inc. (PTHS) support and resistance · rev $16.8M
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
This page maps Pelthos Therapeutics Inc. (PTHS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
PTHS currently screens at market cap $94.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PTHS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PTHS quote page for the session range and the stock page for the full model.
Not investment advice.